VERA:NASDAQ, Vera Therapeutics, Inc.

VERA stock overview

Vera Therapeutics, Inc. (VERA:NASDAQ) closed at $26.75 on November 19, 2026, up 4.57% on the day. The stock trades 52.3% below its 52-week high of $56.05 and 6.7% above its 52-week low of $25.08. Over the past year, it lost 4.0%. Vera Therapeutics, Inc. is part of the Health Care sector.

Key figures

Price
$26.75
Day change
+4.57%
Volume
1,050,255
Average volume
1,959,845
Market cap
1B+
52-week range
$25.08 – $56.05
50-day average
$30.58
200-day average
$35.87

Price action over the past year

In 252 trading sessions since November 19, 2025, VERA closed higher on 111 days (44%). Its best day was November 26, 2025 (+13.25%) and its worst was September 23, 2026 (-8.85%). The stock moved 10% or more in a single session 4 times.

Recent signals

VERA news

About Vera Therapeutics, Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Similar stocks

Find more stocks like VERA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.